abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2007年7月13日

著者:
Business Journal of the Greater Triad Area [USA]

Syngenta reviewing European court decision

In its response to the ruling [by an EU court, banning paraquat, the active ingredient in its product Gramoxone], Syngenta said it was "surprised by the unprecedented decision" to ban the substance, and also by the court's decision to implement the ban immediately even though the European Commission has the right to appeal. The company, which was not directly involved in the court case, said it "remains committed to science-based regulation" and said the 2003 decision "was preceded by a detailed and comprehensive scientific review."

タイムライン